Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 811 results for "avp research"

Bajaj Auto Q1 weak; analyst say volumes may not fall ahead

Prayesh Jain, AVP- Research Analyst, IIFL expected the auto player to post EBITDA of around Rs 1024 crore but the company disappointed by posting just Rs 925 crore. We were expecting the margins to be over 19.8 percent given the company's exports ..., 1 week ago

9 images for avp research

Mideast Time, 2 months ago
American Banking News, 2 months ago
American Banking News, 2 months ago
Mideast Time, 2 months ago
American Banking News, 2 months ago
Mideast Time, 2 months ago
American Banking News, 2 months ago
American Banking News, 4 months ago
Zolmax News, 4 months ago

Removal of STT will be a boost for capital markets: K Subramanyam

K Subramanyam, AVP (institutional research), Asit C. Mehta Securities speaks to Surabhi Roy on the market trends, Budget expectations, Iraq crisis and sectors What strategy should investors adopt in current scenario ahead of the Union Budget? ...
 Smart Investor1 month ago Poll outcome above expectation. Advise buying on dips: K Subramanyam  Business Standard2 months ago

How Edelweiss views TCS growth prospects, Infosys CEO appt

T Discussing the key takeaways from TCS's concall, Sandip Agarwal, AVP - Research, Edelweiss Financial Services, said the management has reiterated that FY15 will be better than FY14. Agarwal expects TCS's FY15 dollar revenue growth in excess of ...
 Moneycontrol.com1 month ago

Hold Sesa Sterlite; target Rs 204: Tarang Bhanushali

Tarang Bhanushali, AVP - Research at IIFL is of the view that one may hold Sesa Sterlite.
 Money Control2 months ago Hold Hindalco, says Tarang Bhanushali  Money Control2 months ago

If Nifty ends below 6,650; selling pressure to intensify

Read on to know Puneet Kinra, AVP Research (Equity Technical), Bonanza Portfolio views Jinsy Mathew | Mumbai May 2, 2014 Last Updated at 11:44 IST Q1 net profit up 2.4% yoy at Rs 39.40 crore against Rs 38.46 crore during the same quarter year ago.
 Business Standard2 months ago

AVP-825 (Migraine) - Forecast and Market Analysis to 2023

/PRNewswire/ -- announces that a new market research report is available in its catalogue: Summary The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to ...
 Industrial Info Financials1 month ago Alzheimer%s Disease Global Clinical Trials Review, H1, 2014  Tutorial Finder1 week ago Global Video Encoders Industry  Broadway World1 month ago Market Report, "Alzheimer's Disease Global Clinical Trials Review, H1, 2014", published  SearchBug1 month ago
American Banking News

Research Analysts Ratings Reiterations for May, 26th (ACXM, AQG, AR, AVP, CHU, DFS, GNC, MDVN, NMBL, PG)

Research Analysts ratings reiterations for Monday, May 26th: Acxiom (NASDAQ:ACXM) Alacer Gold Corp CDI (ASX:AQG) Argonaut Gold (TSE:AR) Avon Products (NYSE:AVP) China Unicom Hong Kong (NYSE:CHU) Discover Financial Services (NYSE:DFS) ...
 American Banking News2 months ago

Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for Major Depressive Disorder

/PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that the U.S. Food and Drug Administration (FDA) accepted the company's Investigational New Drug (IND) application for a Phase II study assessing the safety and efficacy of ...
 Drugs.com1 day ago Avanir's IND for AVP-786 for treatment of MDD receives FDA acceptance  Individual.com4 days ago Avanir Pharmaceuticals Receives FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder  Pharmaceutical & Medical Packaging News1 week ago Avanir Pharmaceuticals Announces Three Data Presentations Related to AVP-825  Finwin1 month ago

Avanir to Conduct Phase II Study on AVP-786 for Depression

Pipeline updates are highly awaited events in the pharma/biotech sector as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give an insight ...
 Yahoo! Finance6 days ago

US FDA accepts Avanir Pharma's IND application for phase II study of AVP-786 for adjunctive treatment of MDD

The US Food and Drug Administration (FDA) has accepted Avanir Pharmaceuticals, Inc.'s Investigational New Drug (IND) application for a phase II study assessing the safety and efficacy of AVP-786, Avanir's next generation compound. The company plans ...
 PharmaBiz1 week ago FDA approves Avanir's Phase II trial of MDD candidate AVP-786  Pharmaceutical Business Review1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less